The clinical utility of metabolomics hinges on reproducibly detecting differences between groups across analytical platforms. A first step toward assuring clinical reliability is establishing the ability to correctly classify heterogeneous mixtures across multiple platforms. No multi-lab studies to date have attempted to use metabolomic profiles to reproducibly cluster heterogeneous mixtures. We evaluated the reproducibility of the TruQuant metabolomics approach in eight labs in the US and UK. Each lab received identical aliquots of 32 samples, containing known mixtures of beef (A), chicken (B), and/or pork (C) extracts of varying homogeneity levels. Metabolomic profiles were generated for each mixture in duplicate using each lab’s LC−MS methods. Anonymized, processed data were analyzed centrally. Despite differences in the number of features detected (560−1727 features), all labs correctly differentiated sample mixture types via unsupervised approaches, with generally strong clustering across labs (NMF-adjusted rand index (ARI) = 1 for all labs except one (ARI = 0.84), unsupervised random forest silhouette score mean = 0.58 ± 0.14). Pearson correlations of suppression-corrected metabolite abundances, compared between lab pairs, were also strong for metabolites that were matched using authentic standards (mean = 0.87 ± 0.12 across all labs). Notably, we evaluated the suitability and impact of different data transformation approaches to make lab-to-lab comparisons. Overall, this “round-robin” study design and data show that metabolomic analyses, with appropriate study designs and data handling, enable reproducible conclusions across labs and platforms.
21 October 2022 in Molecular Nutrition & Food Research
Scope: Colon metabolomes associated with high‐fat (H) versus energy‐restricted (E) diets in early colorectal cancer (CRC) models have never been directly compared. The objectives of this study are to elucidate metabolites associated with diet, aberrant crypt foci (ACF), and diet:ACF interaction, using a lifetime murine model.Methods and results: Three‐week‐old mice consumed control (C), E, or H initiation diets for 18 weeks. ACF formation is initiated weeks 16–21 with azoxymethane injections, followed by progression diet crossover (to C, E, or H) through week 60. Colon extracts are analyzed using ultra‐high‐performance liquid chromatography‐high resolution mass spectrometry (UHPLC‐HRMS). Metabolites associated with diet, ACF, or diet:ACF are determined using regression models (FDR‐adjusted p‐value <0.05). No metabolites are significantly associated with initiation diets, but concentrations of acylcarnitines and phospholipids are associated with C, E, and H progression diets. Purines, taurine, and phospholipids are associated with ACF presence. No significant associations between metabolites and diet:ACF interaction are observed.Conclusions: These results suggest that recent, rather than early‐life, diet is more closely associated with the colon metabolome, particularly lipid metabolism. Results from this study also provide candidate biomarkers of early CRC development and provide support for the importance of early diet on influencing pre‐CRC risk.